Energy metabolism in heart failure and remodelling

JS Ingwall - Cardiovascular research, 2009 - academic.oup.com
Myocytes of the failing heart undergo impressive metabolic remodelling. The time line for
changes in the pathways for ATP synthesis in compensated hypertrophy is: flux through the …

Thin filament mutations: developing an integrative approach to a complex disorder

JC Tardiff - Circulation research, 2011 - Am Heart Assoc
Sixteen years ago, mutations in cardiac troponin (Tn) T and α-tropomyosin were linked to
familial hypertrophic cardiomyopathy, thus transforming the disorder from a disease of the β …

Whole genome sequencing improves outcomes of genetic testing in patients with hypertrophic cardiomyopathy

RD Bagnall, J Ingles, ME Dinger, MJ Cowley… - Journal of the American …, 2018 - jacc.org
Background: Whole genome sequencing (WGS) is a comprehensive genetic testing
approach that reports most types of nucleotide variants. Objectives: This study sought to …

Tri-modal regulation of cardiac muscle relaxation; intracellular calcium decline, thin filament deactivation, and cross-bridge cycling kinetics

BJ Biesiadecki, JP Davis, MT Ziolo, PML Janssen - Biophysical reviews, 2014 - Springer
Cardiac muscle relaxation is an essential step in the cardiac cycle. Even when the
contraction of the heart is normal and forceful, a relaxation phase that is too slow will limit …

Pathogenesis of hypertrophic cardiomyopathy is mutation rather than disease specific: a comparison of the cardiac troponin T E163R and R92Q mouse models

C Ferrantini, R Coppini, JM Pioner… - Journal of the …, 2017 - Am Heart Assoc
Background In cardiomyocytes from patients with hypertrophic cardiomyopathy, mechanical
dysfunction and arrhythmogenicity are caused by mutation‐driven changes in myofilament …

Mechanisms of sympathoadrenal failure and hypoglycemia in diabetes

PE Cryer - The Journal of clinical investigation, 2006 - Am Soc Clin Investig
A reduced sympathoadrenal response, induced by recent antecedent hypoglycemia, is the
key feature of hypoglycemia-associated autonomic failure (HAAF) and, thus, the …

Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathy

S Vakrou, Y Liu, L Zhu, GV Greenland, B Simsek… - Scientific reports, 2021 - nature.com
Hypertrophic cardiomyopathy (HCM) is characterized by phenotypic heterogeneity. We
investigated the molecular basis of the cardiac phenotype in two mouse models at …

A model of calcium activation of the cardiac thin filament

EP Manning, JC Tardiff, SD Schwartz - Biochemistry, 2011 - ACS Publications
The cardiac thin filament regulates actomyosin interactions through calcium-dependent
alterations in the dynamics of cardiac troponin and tropomyosin. Over the past several …

Atomic resolution probe for allostery in the regulatory thin filament

MR Williams, SJ Lehman, JC Tardiff… - Proceedings of the …, 2016 - National Acad Sciences
Calcium binding and dissociation within the cardiac thin filament (CTF) is a fundamental
regulator of normal contraction and relaxation. Although the disruption of this complex …

Cardiac troponin structure-function and the influence of hypertrophic cardiomyopathy associated mutations on modulation of contractility

Y Cheng, M Regnier - Archives of biochemistry and biophysics, 2016 - Elsevier
Cardiac troponin (cTn) acts as a pivotal regulator of muscle contraction and relaxation and is
composed of three distinct subunits (cTnC: a highly conserved Ca 2+ binding subunit, cTnI …